A simple and rapid HPLC-UV method for the determination of valproic acid in human plasma using microwave-assisted derivatization with phenylhydrazine hydrochloride.

Human plasma Hydrazone Microwave assisted derivatization Phenylhydrazine hydrochloride Precolumn derivatization Valproic acid

Journal

Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560

Informations de publication

Date de publication:
30 Mar 2024
Historique:
received: 06 01 2024
revised: 20 02 2024
accepted: 07 03 2024
medline: 28 3 2024
pubmed: 28 3 2024
entrez: 28 3 2024
Statut: epublish

Résumé

This study presents an efficient high-performance liquid chromatography with ultraviolet detection (HPLC-UV) method for monitoring valproic acid (VPA) level in human plasma. This method is distinguished by its simplicity, cost-effectiveness, and rapid execution, addressing the limitations associated with other advanced analytical techniques like liquid chromatography-mass spectrometry (LC-MS), gas chromatography-mass spectrometry (GC-MS), and immunoassays, which are generally complex and costly for routine application. A challenge in analyzing VPA is its non-linear protein binding profile and the absence of a chromophore in its structure, making direct detection difficult. To overcome this, the study developed an efficient HPLC-UV for VPA determination in human plasma, utilizing a simplified and rapid microwave-assisted derivatization process. Due to the lack of a chromophore in VPA structure, this work developed a microwave-assisted derivatization of VPA using phenylhydrazine hydrochloride (PH HCl). The process optimization was achieved at 450 W for 50 s, facilitating effective HPLC-UV detection. The derivatized product was characterized using

Identifiants

pubmed: 38545211
doi: 10.1016/j.heliyon.2024.e27875
pii: S2405-8440(24)03906-9
pmc: PMC10965533
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e27875

Informations de copyright

© 2024 The Authors.

Déclaration de conflit d'intérêts

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Sirikanya Kaewpradit reports financial support was provided by 10.13039/501100010034Walailak University. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Sirikanya Kaewpradit (S)

School of Pharmacy, Walailak University, Thasala, Nakhon Si Thammarat, 80160, Thailand.
Drug and Cosmetics Excellence Center, Walailak University, Thasala, Nakhon Si Thammarat, 80160, Thailand.

Gorawit Yusakul (G)

School of Pharmacy, Walailak University, Thasala, Nakhon Si Thammarat, 80160, Thailand.
Functional Materials and Nanotechnology Center of Excellence, Walailak University, Thasala, Nakhon Si Thammarat, 80160, Thailand.

Pornchai Rojsitthisak (P)

Department of Food and Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, 10330, Thailand.
Center of Excellence in Natural Products for Ageing and Chronic Diseases, Chulalongkorn University, Bangkok, 10330, Thailand.

Chutima Jantarat (C)

School of Pharmacy, Walailak University, Thasala, Nakhon Si Thammarat, 80160, Thailand.
Drug and Cosmetics Excellence Center, Walailak University, Thasala, Nakhon Si Thammarat, 80160, Thailand.

Classifications MeSH